
Benitec Biopharma BNTC
€ 9.67
1.55%
Geschäftsbericht 2025
hinzugefügt 20.03.2026
Benitec Biopharma P/S 2011-2026 | BNTC
P/S Jährlich Benitec Biopharma
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 54.5 | 4.81 | 146 | 79 | 0.751 | 64.9 | 41.9 | 35.1 | 91.6 | 27 | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 146 | 0.751 | 54.5 |
P/S anderer Aktien in der Pharmaeinzelhändler
| Name | P/S | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M | ||
|
Grifols, S.A.
GRFS
|
1.71 | $ 7.71 | 1.65 % | $ 6.83 B | ||
|
Altimmune
ALT
|
7.76 K | $ 3.5 | 4.64 % | $ 308 M | ||
|
I-Mab
IMAB
|
94.1 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
1.96 K | - | 2.54 % | $ 160 B | ||
|
Ascendis Pharma A/S
ASND
|
947 | $ 221.52 | -0.16 % | $ 5 B | ||
|
Heron Therapeutics
HRTX
|
1.28 | $ 0.8 | 2.5 % | $ 133 M | ||
|
Midatech Pharma plc
MTP
|
137 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
65.5 | - | - | $ 26.5 M | ||
|
Aeterna Zentaris
AEZS
|
7.87 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
0.099 | - | -10.17 % | $ 12.2 K | ||
|
Acorda Therapeutics
ACOR
|
0.142 | - | -24.86 % | $ 820 K | ||
|
Albireo Pharma
ALBO
|
13.3 | - | -0.23 % | $ 916 M | ||
|
Acasti Pharma
ACST
|
0.203 | - | 4.01 % | $ 150 M | ||
|
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - | ||
|
Adverum Biotechnologies
ADVM
|
76.4 | - | - | $ 86.2 M | ||
|
Acer Therapeutics
ACER
|
25.8 | - | 2.71 % | $ 14 M | ||
|
Advaxis
ADXS
|
144 | - | -9.65 % | $ 45.9 M | ||
|
Ayala Pharmaceuticals
AYLA
|
11.2 | - | - | $ 7.46 M | ||
|
Incyte Corporation
INCY
|
3.79 | $ 90.82 | 0.04 % | $ 17.7 B | ||
|
BioDelivery Sciences International
BDSI
|
1.85 | - | -4.8 % | $ 255 M | ||
|
BeiGene, Ltd.
BGNE
|
66.4 | - | 0.49 % | $ 251 B | ||
|
InMed Pharmaceuticals
INM
|
0.414 | $ 0.79 | -3.52 % | $ 1.93 M | ||
|
INmune Bio
INMB
|
1.36 K | $ 1.23 | 5.13 % | $ 22.1 M | ||
|
Inovio Pharmaceuticals
INO
|
265 | $ 1.57 | -0.95 % | $ 34.8 M | ||
|
Innate Pharma S.A.
IPHA
|
14.7 | $ 1.34 | 14.26 % | $ 235 M | ||
|
Calithera Biosciences
CALA
|
98.5 | - | -10.95 % | $ 876 K | ||
|
Cara Therapeutics
CARA
|
2.58 | - | -3.03 % | $ 260 M | ||
|
ChemoCentryx
CCXI
|
0.0564 | - | - | $ 3.74 B | ||
|
Checkpoint Therapeutics
CKPT
|
3.91 K | - | - | $ 169 M | ||
|
Clovis Oncology
CLVS
|
1.55 | - | -7.23 % | $ 13 M | ||
|
Inventiva S.A.
IVA
|
128 | $ 6.09 | 5.36 % | $ 138 M | ||
|
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
281 | - | - | $ 867 M | ||
|
Compugen Ltd.
CGEN
|
49.8 | $ 2.13 | 1.91 % | $ 199 M | ||
|
KalVista Pharmaceuticals
KALV
|
11.4 | $ 16.93 | -0.41 % | $ 841 M | ||
|
CorMedix
CRMD
|
0.00146 | $ 6.35 | 1.6 % | $ 457 K | ||
|
Arbutus Biopharma Corporation
ABUS
|
24.5 | $ 4.33 | 2.12 % | $ 719 M | ||
|
Kamada Ltd.
KMDA
|
2.61 | $ 8.33 | 0.97 % | $ 260 M |